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ABSTRACT
OBJECTIVES
Small-for-gestational-age fetuses (SGA) are at high-risk of intrapartum fetal
compromise requiring operative delivery. In a recent study, we developed a
model using a combination of three antenatal (gestational age at delivery, parity,
cerebroplacental ratio) and three intrapartum (epidural use, labor induction and
augmentation using oxytocin) variables for the prediction of operative delivery due
to presumed fetal compromise in SGA fetuses – the Individual RIsk aSsessment
(IRIS) prediction model. The aim of this study was to test the predictive accuracy
of the IRIS prediction model in an external cohort of singleton pregnancies
complicated by SGA.
METHODS
This was an external validation study using a cohort of pregnancies from two
tertiary referral centers in Spain and England. The inclusion criteria were singleton
pregnancies diagnosed with an SGA fetus, defined as EFW below the 10th centile
for gestational age at 36 weeks or beyond, which had fetal Doppler assessment
and available data on their intrapartum care and pregnancy outcomes. The main
outcome in this study was the operative delivery for presumed fetal compromise.
External validation was performed using the coefficients obtained in the original
development cohort. The predictive accuracies of models were investigated with
receiver operating characteristics (ROC) curves. The Hosmer-Lemeshow test
was used to test the goodness-of-fit of models and calibration plots were also
obtained for visual assessment. A mobile application using the combined model
algorithm was developed to facilitate clinical use.
RESULTS
412 singleton pregnancies with an antenatal diagnosis of SGA were included
in the study. The operative delivery rate was 22.8% (n=94). The group which
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required operative delivery for presumed fetal compromise had significantly fewer
multiparous women (19.1% vs 47.8%, p<0.001 in the total study population;
19.0% vs 43.5% and 19.2% vs. 49.6%, UK and Spain cohort, respectively), lower
CPR MoM (median: 0.77 vs 0.92, p<0.001 in the total study population; 0.77 vs
0.92 and 0.77 vs 0.92 , UK and Spain cohort, respectively), more inductions of
labor (74.5% vs 60.1%, p=0.010 in the total study population; 85.7% vs 77.2%
and 71.2% and 53.1, UK and Spain cohort, respectively) and more use of oxytocin
augmentation (57.4% vs 39.3%, p=0.002 in the total study population; 19.0% vs
12.0% and 68.5% and 50.4%, UK and Spain cohort, respectively) compared to
those who did not require operative delivery due to presumed fetal compromise.
When the original antenatal model was applied to the present cohort, we observed
moderate predictive accuracy (AUC: 0.70, 95% CI: 0.64-0.76), and no signs of
poor fit (p=0.464). The original combined model, when applied to the external
cohort, had moderate predictive accuracy (AUC: 0.72, 95% CI: 0.67-0.77) and
also no signs of poor fit (p=0.268) without the need for refitting. A statistically
significant increase in the predictive accuracy was not achieved via refitting of the
combined model (AUC 0.76 vs 0.72, p=0.060).
CONCLUSIONS
Using our recently published model, the predictive accuracy for fetal compromise
requiring operative delivery in term fetuses thought to be SGA was modest and
showed no signs of poor fit in an external cohort. The IRIS tool for mobile devices
has been developed to facilitate wide clinical use of this prediction model.JU
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Brief rationale
Objective: To determine the external validity of an intrapartum risk prediction model for
suspected small-for-gestational age fetuses. 
What is already known: Small-for-gestational age foetuses are at increased risk of
intrapartum compromise. Fetal weight alone is a poor marker for adverse outcomes and
a comprehensive prediction model has been previously suggested. 
What this study adds: Multivariable prediction model showed good accuracy and
calibration in this external validation study. The significance of some variables was
different between the original and external validation cohort and there was a small margin
for improvement with model refitting. A mobile application has been developed to facilitate
clinical use. 
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INTRODUCTION
Small-for-gestational-age fetuses (SGA) are at high-risk of intrapartum fetal
compromise, operative delivery, perinatal morbidity and demise [1-6]. Failure to
detect SGA fetuses during the antenatal period is associated with increased
perinatal morbidity and mortality [7-9]. However, the incidence of adverse
outcome in the pregnancies with SGA fetus near term is relatively small [10].
Differentiation of cases truly at risk for adverse outcomes from constitutionally
small fetuses is therefore essential for the management of SGA. Unfortunately,
estimated fetal weight (EFW) alone is a poor predictor of adverse outcomes,
and therefore, additional markers are needed [11-13]. Cerebroplacental ratio
(CPR) has emerged as an important Doppler index for the prediction of adverse
outcomes in SGA fetuses [14-17]. A low CPR is associated with increased risk
of neonatal unit admission, intrapartum fetal compromise and need for operative
delivery [14-17]. When used in conjunction with other antenatal and intrapartum
variables, CPR has the potential to be used for the prediction of adverse outcomes
such as operative delivery and neonatal unit admission [4,6].
In a recent study, we developed a model using a combination of three antenatal
and three intrapartum variables for the prediction of operative delivery due to
presumed fetal compromise in SGA fetuses – the Individual RIsk aSsessment
(IRIS) prediction model [4]. Such a prediction model could be helpful for risk
stratification of SGA fetuses and patient counseling regarding the timing and
mode of birth. However, prediction models are known to overestimate the
predictive accuracy in the development cohort. Validation studies are required to
assess the performance of such models in different populations [18]. The aim of
this study was to test the predictive accuracy of the IRIS prediction model in an
external cohort of SGA pregnancies.
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METHODS
This was an external validation study using two cohorts of pregnancies from two
tertiary referral centers in Spain and England. Pregnancies over a 5-year period
(2012-2017) in Spain (Hospital Universitario y Politecnico la Fe) and over a 2-
year period (2016-2018) in UK (St. George’s University Hospital) were used. None
of these pregnancies were included in the development of the prediction model.
The inclusion criteria were singleton pregnancies diagnosed with an SGA fetus,
defined as EFW below the 10th centile for gestational age at 36 weeks or beyond
with complete Doppler assessment (including umbilical and middle cerebral
artery) within one month prior to the delivery and also complete intrapartum
information (induction, augmentation and epidural use). Further details on how
the prediction models were built can be found in the original study. [4] Model
variables were routinely recorded in St. George’s Hospital (UK cohort). In the
Universitario y Politecnico la Fe Hospital (Spanish cohort), Doppler variables
were not routinely recorded, and therefore only the cases with complete fetal
Doppler assessment (which were routinely performed by a single operator; JM)
were included in the analysis. Pregnancies complicated by major structural fetal
abnormalities, aneuploidy or genetic syndromes were excluded from the analysis.
Moreover, pregnancies that had an elective cesarean delivery were also excluded
from the analysis. Gestational age (GA) was calculated from the crown-rump
length measurement at 11-13 weeks and only one (the last) examination per
pregnancy was included in the analysis [19]. Rarely, for pregnancies in which the
first ultrasound was performed in the second trimester (>14 weeks’ gestation), the
pregnancy was dated according to the head circumference. Routine fetal biometry
was performed according to a standard protocol and the EFW was calculated
using the Hadlock formula [20].The umbilical artery (UA) and middle cerebral
artery (MCA) Doppler waveforms were recorded using color Doppler, and the
pulsatility index (PI) was calculated according to a standard protocol [21]. In brief,
the MCA PI values were obtained in the space where the artery passes by the
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sphenoid wing close to the Circle of Willis, and the UA PI values were obtained in
free loops of umbilical cord. The Doppler measurements were performed within
four weeks of delivery. The measurements were obtained in the absence of fetal
movement, and keeping the insonation angle with the examined vessels less than
30◦.The CPR was calculated as the simple ratio between the MCA PI and the
UA PI. All Doppler indices and biometry variables were converted into multiples
of median (MoM) and centiles correcting for GA using reference ranges, and
birthweight values were converted into centiles [22-24]. Antenatal follow-up and
delivery were managed by separate teams. The CPR and relevant measures
(multiples of median) were not calculated before the analysis of this study.
Intrapartum data included whether the labor was induced or spontaneous, use
of oxytocin for slow progress of labor, use of epidural analgesia for labor, and
mode of delivery. Data on the maternal baseline characteristics and the pregnancy
outcomes were collected from the hospital obstetric records. The main outcome
in this study was the operative delivery for presumed fetal compromise. Operative
delivery for presumed fetal compromise included both cesarean delivery and
instrumental delivery. The diagnosis of fetal compromise was based on CTG
abnormalities (as defined in Sociedad Espanola de Ginecologia y Obstetricia
(SEGO) and National Institute for Health and Care Excellence (NICE) guidelines
for Spain and UK cohorts, respectively), abnormal fetal scalp blood sample pH
(pH<7.20), or a combination of these [25,26].SEGO and NICE guidelines are
similar to one other in terms of criteria for diagnosing abnormal CTG traces.
Statistical analysis
Continuous variables were presented as median with interquartile range, while
binary variables were presented as a fraction of the total with percentages.
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Distribution assumptions were tested with Shapiro-Wilk test. Group comparisons
of variables were performed with t-test, Mann-Whitney-U test or Fisher’s exact
test where appropriate. External validation was performed using the coefficients
obtained in the original development cohort. Possible explanations for poor fitting
or suboptimal predictive accuracy were investigated by refitting the model to
the external validation cohort. The cohort site (England or Spain) was used
as a factor and possible interactions between explanatory variables and cohort
site was investigated during model refitting (P<0.10 was deemed significant for
interaction). Parameter estimates of the original model and refitted models were
used to predict the probability of operative delivery in the external validation
cohort using an inverse logit function. The predicted probabilities were then
used for diagnostic procedures, such as predictive accuracy and goodness-
of-fit assessment. The predictive accuracies of models were investigated with
receiver operating characteristics (ROC) curves. The accuracy values (true
positive + true negative / total) of each model for different risk cut-offs were also
calculated. A Bayesian framework was used to calculate the posterior probability
of improvement in accuracy, sensitivity and specificity for each risk cut-off. The
predictive markers of accuracy, sensitivity and specificity were modeled using
binomial distribution for the likelihood function and Beta distribution (0.5,0.5) for
the prior function. A random-walk metropolis algorithm was used and Markov
Chain Monte Carlo (MCMC) simulations were run for 200.000 iterations. Separate
ROC curves were also obtained for two cohort sites to investigate the site-
specific differences in the predictive accuracy of the model. Comparisons of ROC
curves were made with De Long’s test. The confidence intervals for the accuracy
values were calculated with 10.000 stratified bootstrap replicates. The Hosmer-
Lemeshow test was used to test the goodness-of-fit of models and calibration
plots were also obtained for visual assessment. We aimed for approximately 100
operative delivery cases in our validation cohort as suggested in the literature
for minimizing optimism in external validation studies [27]. The statistical analysis
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was performed using the RStudio (Version 1.1.419, RStudio, Inc.) statistical
software [28].
The Individual RIsk aSsessment (IRIS) mobile application
The algorithm used in this study was implemented in a
mobile phone application and it is available free-of-charge for
Android and iOS mobile devices in their respective application
stores (https://goo.gl/qo31Rm & https://itunes.apple.com/us/app/iris-tool-for-sga-
babies/id1371991518?ls=1&mt=8 ). The mobile application uses the combined
model and requires gestational age at delivery, parity, CPR, epidural use, labor
augmentation and induction information to calculate individual risk of operative
delivery in terms of percentage probability.
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RESULTS
We identified 490 singleton pregnancies with an antenatal diagnosis of SGA fetus
which were eligible for inclusion (344 in the Spanish cohort and 146 in the UK
cohort). After excluding elective Cesarean sections (n=66), fetal anomalies (n=3),
stillbirth cases (n=3), and cases with missing variables (n=6), 412 pregnancies
with an operative delivery rate of 22.8% (n=94) were included in the study
(Figure 1). The total number of operative delivery cases due to presumed fetal
compromise was 73 (24.4%) in the Spanish cohort and 21 (18.6%) in the UK
cohort. The incidence of Cesarean delivery rate in the study cohort was 14.3%
(n=59) and that of the instrumental delivery due to presumed fetal compromise
was 8.5% (n=35). The accuracy of the antenatal ultrasound to detect SGA at birth
was 87.6% and 82.6% for UK and Spain cohort, respectively.
The antenatal, intrapartum and birth characteristics of the study cohort stratified
according to the location are shown in Table 1. The group which required operative
delivery for presumed fetal compromise had significantly fewer multiparous
women (19.1% vs 47.8%, p<0.001 in the total study population; 19.0% vs 43.5%
and 19.2% vs. 49.6%, UK and Spain cohort, respectively), lower CPR MoM
(median: 0.77 vs 0.92, p<0.001 in the total study population; 0.77 vs 0.92 and
0.77 vs 0.92 , UK and Spain cohort, respectively), more inductions of labor (74.5%
vs 60.1%, p=0.010 in the total study population; 85.7% vs 77.2% and 71.2% and
53.1, UK and Spain cohort, respectively) and more use of oxytocin augmentation
(57.4% vs 39.3%, p=0.020 in the total study population; 19.0% vs 12.0% and
68.5% and 50.4%, UK and Spain cohort, respectively) compared to those who did
not require operative delivery due to presumed fetal compromise. The neonates
delivered via operative delivery for presumed fetal compromise also had lower
birthweight centiles (P=0.014 and P<0.001, UK and Spain cohort, respectively).
The validation of the original antenatal and combined models was performed
using the original model coefficients and with re-estimated model coefficients
(Table 2). When the original antenatal model was applied to the present cohort,
we observed moderate predictive accuracy (AUC 0.70, 95% CI 0.64-0.76, Figure
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2), and good fit (p=0.464). Visual estimation of the model fit with calibration plot
showed that the original antenatal model slightly underestimated the probability of
operative delivery due to presumed fetal compromise (Supplementary Figure 1).
When the variables were refitted to the present cohort, only parity and CPR MoM
remained as significant predictors (Table 2). The refitted model showed similar
predictive accuracy compared to the original antenatal model (AUC 0.73, 95% CI
0.67-0.79; De Long’s test, p=0.076, Figure 1) and poor-fit according to Hosmer-
Lemeshow test (p=0.008) (Supplementary Figure 2).
When the original combined model was applied to the present cohort, we
observed moderate predictive accuracy (AUC 0.72, 95% CI 0.67-0.77, Figure 3)
and good fit (p=0.268). When variables were refitted to the present cohort, only
parity, CPR MoM, labor induction and oxytocin augmentation remained significant
predictors (Table 2). Furthermore, when the cohort site was used as a factor, there
was a borderline significant effect for interaction between cohort site and epidural
use (p=0.079) and cohort site was a borderline significant factor on its own as well
(p=0.075). The refitted model showed statistically non-significant improvement
in the predictive accuracy compared to the original antenatal model (AUC 0.76,
95% CI 0.70-0.81 vs AUC 0.72, 95% CI 0.67-0.77, p=0.060, Figure 3) and also
good-fit (p=0.545) (Supplementary Figures 3 and 4). The predictive accuracy
values of the original and refitted combined models can be seen in Table 3. The
risk cut-offs between 30% and 40% offered the most balanced sensitivity and
specificity values. The posterior probabilities indicated that the chance of accuracy
improvement with model refitting is highly probable for risk cut-off ranges between
10% and 40% at the cost of reduced sensitivity (Table 3). We also performed
a sensitivity analysis for each cohort site and found no evidence of significant
differences in the predictive accuracy according to ROC curves (Supplementary
Figure 5).
The external validation shows that the original combined model has moderate
predictive accuracy (AUC 0.72) and goodness-of-fit (p=0.268) when used in an
external cohort without the need for refitting. 
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DISCUSSION
Main findings
The predictive accuracy for fetal compromise requiring operative delivery of our
model was modest and showed no signs of poor fit in an external cohort of
pregnancies with suspected SGA fetuses at term. Although the re-estimation of
combined model variables did not significantly improve the predictive accuracy
Bayesian framework analysis indicated accuracy improvement is probable at
the expense of sensitivity. The IRIS application for mobile devices has been
developed to facilitate the clinical use of this prediction model.
Interpretation of the findings and comparison with existing literature
There were some demographic and clinical differences between the original
cohort and the external validation cohort. When the model parameters were re-
estimated using the validation cohort, we observed some variables - namely
epidural use and GA at delivery - which no longer appeared important for
predicting operative delivery. The estimated effect of GA at delivery was similar
to the original cohort, albeit with a larger confidence interval probably because
of the smaller number of pregnancies in the external validation cohort compared
to the original cohort. This finding may affect the 95% CI estimation, but does
not necessarily imply a lack of casual relationship. Interestingly, the direction of
effect of the epidural analgesia was towards reduced risk in the external validation
cohort, which is contrary to the original cohort. However, there was a borderline
significant interaction between the cohort site and epidural use with the UK cohort
showing an increased risk with the epidural use (P=0.079). This difference can
be explained by the effect of epidural analgesia on labor outcomes, which is
quite heterogeneous in the literature and is influenced by local clinical practices
[29]. Furthermore, the original and part of the validation cohort used different
guidelines for the diagnosis of presumed fetal compromise that could also explain
the observed difference in the rates of operative delivery. Despite these potential
limitations, the combined model proved useful in predicting adverse outcomes in
the validation cohort with no significant differences between the cohort sites.
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Clinical and research implications
Prediction models are aimed at helping clinicians with decision-making and are
developed relatively frequently for many medical situations. Unfortunately, their
usefulness largely relies on the population they are being used and it is not
uncommon to observe greatly diminished predictive accuracy when a model
is tested on an external cohort [30]. External validation studies are therefore
crucial before the prediction models can be used in clinical practice. Unfortunately,
external validation studies which adequately report the diagnostic performance
measures of a model are rare [31]. Our combined model is one of the few
multivariable models which aimed to predict adverse outcome in appropriate-for-
gestational-age (AGA) or SGA fetuses [32-35].The combined model had an AUC
of 0.72 in an external cohort without refitting which is more than the 0.70, a value
considered as a fair performance indicator and is also a threshold for clinical
usefulness.
Prognostic markers that are associated with adverse outcomes in SGA fetuses
are useful. However, the translation of statistical findings into clinical practice is
problematic due to the lack of practical tools. The IRIS mobile app, which uses our
combined model algorithm, is an easy to use application that can facilitate clinical
translation of our findings. Individualized risk assessment could help physicians
with decision making. For example, with the use of mobile application, it would
be feasible to reassure the mother of a low-risk fetus to proceed with vaginal
delivery plans or to see the added risk of labor augmentation by comparing it to
the baseline risk due to unmodifiable risk factors (gestational age, CPR MoM,
parity).
The development of a prediction model is an arduous process and assessment
of its clinical utility is an important final step [36,37]. Our prediction model can be
helpful in identifying fetuses at an increased risk of intrapartum fetal compromise.
Improved identification of such fetuses may reduce the incidence of fetuses born
with acidemia, but may also inadvertently increase the rate of elective cesarean
section. It is also possible that an increase in cesarean section rates may not
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result in a decline in adverse fetal outcomes. Future studies are needed to test
the utility and effectiveness of the IRIS tool mobile app.
Study strengths and limitations
We reported both the accuracy and goodness-of-fit measures as recommended
by experts in study methodology [31]. Our model was aimed at a specific
outcome measure as opposed to other studies which used a composite adverse
outcome measure [32]. This is quite important as outcomes such as the operative
delivery and neonatal unit admission which are usually blanketed under the same
category, can have different prognostic and confounding variables [4,6]. The
CPR values were not calculated before the analysis for this study, and therefore,
limiting the effect of intervention bias on the results we have obtained. However,
eliminating the intervention bias in a retrospective cohort is not possible and it
is possible that our results are confounded by intervention bias. A prospective
randomized trial is needed to assess the usefulness of CPR for the prevention
of adverse outcomes [38]. We had a smaller number of suspected SGA fetuses
in the validation cohort than the original cohort which was used to develop the
prediction model. Also, we could not reach the recommended number of minimum
outcomes for external validation studies (recommended 100 vs 94 current),
despite including cases from two study centers. Finally, despite the results we
have obtained here, this external validation study was performed on a small cohort
from two institutions and we cannot confirm similar performance of the model in
other populations.
Conclusion
The prediction model has modest predictive accuracy and goodness-of-fit without
the need for refitting. An IRIS mobile app is available for clinicians who wish to
use the predictive model in their clinical practice.
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Table 1. Characteristics of the external validation cohort grouped according to the
method of delivery.JU
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UK cohort
(n=113)
Spain cohort
(n=299)
Operative
delivery*
(n=21)
No
operative
delivery*
(n=92)
P † Operative
delivery*
(n=73)
No operative
delivery*
(n=226)
P †
Antenatal variables
Maternal age
(years)
31.0
(27.0-36.0)
29.0
(25.8-35.0)
0.212 31.0
(28.0-36.0)
32.0
(28.0-36.0)
0.973
Multiparous 4 (19.0) 40 (43.5) 0.047 14 (19.2) 112 (49.6) <0.001
Ultrasound and Doppler variables
Gestational age
at ultrasound
(weeks)
37.7
(36.7-38.4)
37.4
(36.7-38.1)
0.250 39.0
(37.7-39.6)
38.9
(38.0-39.7)
0.767
Interval between
ultrasound and
delivery (days)
4.0
(1.0-12.0)
7.0
(3.0-14.3)
0.055 5.0 (2.0-9.0) 8.0 (2.0-9.0) 0.642
Biparietal diameter
(mm)
90.1
(88.3-93.0)
89.0
(86.5-91.0)
0.109 88.0
(86.0-90.0)
87.0
(84.0-90.0)
0.201
Biparietal diameter
centile
34.1
(18.1-65.1)
28.9
(10.7-57.6)
0.411 7.3 (1.1-17.6) 3.5 (0.4-12.6) 0.130
301.8
(286.8-313.6)
298.5
(288.4-307.5)
0.658 312.0
(302.0-320.0)
312.0
(300.0-319.0)
0.569
JU
ST
 AC
CE
PT
ED
Abdominal
circumference
(mm)
Abdominal
circumference
centile
0.6 (0.1-3.4) 0.7 (0.2-2.5) 0.701 1.24 (0.3-4.3) 1.1 (0.2-3.8) 0.354
Femur length
(mm)
66.3
(64.3-68.0)
67.0
(65.0-69.0)
0.406 66.0
(64.0-68.0)
66.0
(64.0-68.0)
0.653
Femur length
centile
0.5 (0.1-1.4) 1.7 (0.7-5.2) 0.008 0.0 (0.0-0.5) 0.1 (0.0-0.6) 0.947
Estimated fetal
weight (grams)
2467.0
(2189.0-2638.0)
2377.0
(2231.0-2595.0)
0.557 2563.0
(2325.0-2714.0)
2497.0
(2327.0-2656.0)
0.340
Estimated fetal
weight centile
3.7 (2.5-6.6) 6.0 (3.5-8.8) 0.092 4.2 (2.2-6.1) 3.3 (1.6-5.7) 0.090
Umbilical artery PI 0.90
(0.79-1.11)
0.89
(0.80-1.03)
0.676 0.93
(0.82-1.16)
0.88
(0.78-1.02)
0.004
Umbilical artery PI
MoM
1.03
(0.90-1.28)
1.02
(0.90-1.17)
0.453 1.12
(0.96-1.36)
1.04
(0.93-1.18)
0.004
Middle cerebral
artery PI
1.32
(1.07-1.44)
1.48
(1.32-1.71)
0.001 1.25
(1.09-1.50)
1.45
(1.22-1.73)
<0.001
Middle cerebral
artery PI MoM
1.03
(0.96-1.17)
1.18
(1.06-1.33)
0.002 1.12
(0.95-1.33)
1.27
(1.10-1.53)
<0.001
Cerebroplacental
ratio
1.43
(1.00-1.64)
1.70
(1.39-2.03)
0.004 1.36
(0.98-1.72)
1.60
(1.31-2.06)
<0.001
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Cerebroplacental
ratio MoM
0.77
(0.62-0.91)
0.92
(0.77-1.10)
0.008 0.77
(0.56-0.95)
0.92
(0.75-1.16)
<0.001
Intrapartum variables
Induction of labor 18 (85.7) 71 (77.2) 0.556 52 (71.2) 120 (53.1) 0.006
Oxytocin use for
labor
augmentation
4 (19.0) 11 (12.0) 0.474 50 (68.5) 114 (50.4) 0.009
Epidural use 12 (57.1) 22 (23.9) 0.006 57 (78.1) 164 (72.6) 0.443
Variables at birth
Gestational age at
delivery (weeks)
38.3
(38.1-40.0)
38.9
(38.1-39.6)
0.997 39.7
(38.9-40.6)
39.9
(38.9-40.4)
0.688
Birthweight
(grams)
2300.0
(2172-2600.0)
2545.0
(2295.0-2750.0)
0.060 2550.0
(2380.0-2750.0)
2705.0
(2450.0-2870.0)
0.003
Birthweight centile 1.5 (0.6-3.2) 3.4 (1.5-7.6) 0.014 1.9 (0.8-3.4) 4.1 (1.5-8.3) <0.001
Small for
gestational age
21 (100.0) 78 (84.8) 0.068 68 (93.2) 179 (79.2) 0.006
Neonatal care unit
admission
2 (9.5) 5 (5.4) 0.617 12 (16.4) 19 (8.4) 0.035
*For presume fetal compromise
†Group comparisons were made with either t-test, Mann-Whitney-U or Fisher’s
exact test.
MoM: multiple of median, PI: pulsatility index
Data provided as median and interquartile range (IQR) or number (percentage).
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Table 2. The parameter estimates of prediction models for the original and
external validation cohorts.
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Odds ratio, 95% CI
(Original prediction
model)*
p-
value
Odds ratio, 95% CI
(Refitted model for
validation cohort)*
p-
value
Antenatal model variables
Intercept 0.69 (0.38-1.26) 0.239 2.58 (1.10-6.21) 0.042
Multiparity 0.27 (0.17-0.41) <0.001 0.27 (0.15-0.48) <0.001
Abdominal circumference
centile
0.96 (0.93-0.99) 0.027 1.02 (0.98-1.07) 0.320
Gestation over 39 weeks’ at
delivery
1.97 (1.36-2.90) <0.001 1.40 (0.83-2.40) 0.157
Cerebroplacental ratio MoM 0.33 (0.16-0.66) 0.002 0.09 (0.03-0.25) <0.001
Combined model variables
Intercept 0.19 (0.09-0.40) <0.001 2.74 (0.45-16.26) 0.266
Augmentation of labor 3.09 (1.60-5.90) <0.001 3.16 (1.19-8.79) 0.022
Induction of labor 2.26 (1.44-3.59) <0.001 3.06 (1.32-7.68) 0.012
Epidural analgesia 2.73 (1.89-3.94) <0.001 0.31 (0.05-1.87) 0.196
Gestation over 39 weeks’ at
delivery
1.65 (1.12-2.46) 0.011 1.42 (0.82-2.51) 0.217
Cerebroplacental ratio MoM 0.35 (0.16-0.72) 0.005 0.10 (0.04-0.28) <0.001
Multiparity 0.36 (0.23-0.56) <0.001 0.32 (0.17-0.57) <0.001
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Interaction term for
induction of labor
and augmentation using
oxytocin
0.43 (0.19-0.95) 0.037 0.30 (0.09-0.94) 0.041
Cohort location
-Spain NA NA Reference
-UK NA NA 0.40 (0.14-1.08) 0.075
Interaction term for epidural
and cohort location
NA NA 3.07 (0.88-10.9) 0.079
*Parameter estimates were obtained via generalized linear models using a logit
link.
CI: confidence interval, MoM: multiple of median
Table 3. Diagnostic accuracy parameters of the original and refitted combined
model for different risk cut-offs.
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Diagnostic accuracy
parameters
Original combined
model
Refitted combined
model
Posterior
probability†
Risk cut-off >10%
 - Accuracy* 44.4% (39.6-49.4%) 50.2% (45.3-55.2%) 95.1%
-Sensitivity 95.7% 95.7% 50.3%
-Specificity 29.3% 36.8% 80.8%
Risk cut-off >20%
 - Accuracy 57.3% (52.4-62.1%) 63.3% (58.5-68.0%) 96.7%
-Sensitivity 81.9% 72.3% 5.6%
-Specificity 50.0% 60.7% 99.7%
Risk cut-off >30%
 - Accuracy 67.2% (62.5-71.8%) 73.3% (68.8-77.5%) 97.1%
-Sensitivity 63.8% 56.4% 14.2%
-Specificity 68.2% 78.3% 99.8%
Risk cut-off >40%
 - Accuracy 70.9% (66.2-75.2%) 76.9% (72.6-80.9%) 97.6%
-Sensitivity 43.6% 40.4% 34.7%
-Specificity 78.9% 87.7% 96.2%
Risk cut-off >50%
 - Accuracy 76.0% (71.2-80.0%) 78.6% (74.4-82.5%) 82.3%
-Sensitivity 22.3% 22.3% 50.8%
-Specificity 91.8% 95.3% 96.3%
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Percentages are given as mean estimates and 95% confidence intervals within the brackets
* The confidence intervals for the accuracy estimates were calculated with 10.000 stratified
bootstrap replicates
†Posterior probabilities of improvement in diagnostic accuracy via model refitting were calculated
using a Bayesian framework(Likehood~Binomial(n,p); Prior~Beta(0.5,0.5))
CI: confidence interval, FPR: false positive rate
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Figure 1. Patient enrollment flow-chart.
Figure 2. Receiver operating characteristics curves for the antenatal model
using the original (dashed lines) and re-estimated coefficients (straight line). The
De Long test indicated statistically non-significant improvement in the model
accuracy with refitting (AUC 0.73, 95% CI: 0.67-0.79 vs AUC 0.70, 95% CI:
0.64-0.76, refitted and original antenatal model respectively, P=0.076)
Figure 3. Receiver operating characteristics curves for the combined model
using the original (dashed lines) and re-estimated coefficients (straight line). The
De Long test indicated a statistically non-significant improvement in the model
accuracy with refitting (AUC 0.76, 95% CI: 0.70-0.81 vs AUC 0.72, 95% CI:
0.67-0.77, refitted and original combined model respectively, P=0.060)
Supplement Figure 1. The calibration plot for the antenatal model using the
original regression coefficients. The black line represents the predicted means
and yellow area represents the confidence intervals. Deviation from the redline
indicates predicted and observed averages are incongruent. The Hosmer-
Lemeshow test indicated no significant effect for poor-fit (P=0.464).
Supplement Figure 2. The calibration plot for the antenatal model using the
re-estimated regression coefficients. The black line represents the predicted
means and yellow area represents the confidence intervals. Deviation from the
redline indicates predicted and observed averages are incongruent. The Hosmer-
Lemeshow test indicated a significant effect for poor-fit (P=0.008).
Supplement Figure 3. The calibration plot for the combined model using
the original regression coefficients. The black line represents the predicted
means and yellow area represents the confidence intervals. Deviation from the
redline indicates predicted and observed averages are incongruent. The Hosmer-
Lemeshow test indicated no significant effect for poor-fit (P=0.268).
Supplement Figure 4. The calibration plot for the combined model using the
re-estimated regression coefficients. The black line represents the predicted
means and yellow area represents the confidence intervals. Deviation from the
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redline indicates predicted and observed averages are incongruent. The Hosmer-
Lemeshow test indicated no significant effect for poor-fit (P=0.545).
Supplement Figure 5. Receiver operating characteristics curves for the antenatal
(a) and combined (b) model for the Spanish cohort (straight lines) and UK
cohort (dashed lines) using the original model coefficients. There were no
significant differences between cohort locations regarding predictive accuracy for
the combined model (Area under the curve: 0.71 vs 0.73, Spain and England,
respectively. P=0.755) and the antenatal model (Area under the curve: 0.70 vs
0.66, Spain and UK, respectively. P=0.531).
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